{"id":"thiamazole","brandName":"thiamazole","genericName":"thiamazole","companyId":"unknown","companyName":"","phase":"unknown","status":"active","modality":"","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"Thiamazole, also known as methimazole, is a medication used to treat hyperthyroidism, including conditions such as Graves' disease and toxic multinodular goiter. It works by inhibiting thyroid peroxidase, a key enzyme in the production of thyroid hormones.","enrichmentLevel":3,"visitCount":0,"mechanism":{"target":"Lactoperoxidase, Taste receptor type 2 member 38, Thyroid peroxidase"},"administration":{},"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Agranulocytosis","Bone marrow depression","Drug-induced hepatitis","Factor II deficiency","Hypothyroidism","Leukopenia","Liver function tests abnormal","Pancytopenia","Pregnancy, function","Thrombocytopenic disorder"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":["NCT05043233","NCT05017610","NCT06570967","NCT04135573","NCT05118542","NCT01893450","NCT01458600","NCT05607407","NCT06540469","NCT02727738","NCT00150124","NCT07369063","NCT05964452","NCT00677469","NCT04304794","NCT02812888","NCT01849861","NCT06068179","NCT06327828","NCT04346901","NCT00150137","NCT01247077","NCT06864351","NCT06240455","NCT00150111","NCT07040306","NCT02654041","NCT03447093","NCT03433352","NCT00001421","NCT03390582","NCT02376088","NCT04776993","NCT03064542","NCT01560299","NCT03066076","NCT00917241","NCT04946123","NCT05461820"],"indications":{"approved":[{"name":"Hyperthyroidism","diseaseId":"hyperthyroidism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[{"nctId":"NCT05043233","phase":"N/A","title":"The Observation Study of Graves' Disease Cohort","status":"UNKNOWN","sponsor":"Shanghai Jiao Tong University School of Medicine","isPivotal":false,"enrollment":1000,"indication":"Patient Acceptance of Health Care","completionDate":"2025-10-01"},{"nctId":"NCT05017610","phase":"EARLY/Phase 1","title":"A Single Arm Pilot Study to Evaluate the Safety and Feasibility of Inducing a Hypothyroxinemic State in Patients With Recurrent Glioblastoma","status":"WITHDRAWN","sponsor":"Emory University","isPivotal":false,"enrollment":0,"indication":"Recurrent Glioblastoma, Recurrent Gliosarcoma","completionDate":"2022-10-14"},{"nctId":"NCT06570967","phase":"N/A","title":"A Retrospective and Prospective Observational Study of Hyperthyroidism in Children","status":"RECRUITING","sponsor":"Shengjing Hospital","isPivotal":false,"enrollment":1000,"indication":"Hyperthyroidism","completionDate":"2027-12"},{"nctId":"NCT04135573","phase":"N/A","title":"Mechanism of NK Cell Disfunction in Graves' Disease","status":"UNKNOWN","sponsor":"Shandong Provincial Hospital","isPivotal":false,"enrollment":200,"indication":"Graves Disease","completionDate":"2022-06-30"},{"nctId":"NCT05118542","phase":"Phase 3","title":"Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis: Review on the Pathway of Insulin Resistance, Lipid, Inflammation, and Endothelial Dysfunction to Puls","status":"COMPLETED","sponsor":"Indonesia University","isPivotal":true,"enrollment":36,"indication":"Hyperthyroidism, Graves Disease","completionDate":"2020-08-01"},{"nctId":"NCT01893450","phase":"NA","title":"Comparison of the Effect of Bromocriptine and Pentoxifylline in Mild to Moderate Autoimmune Ophthalmopathy. A Randomized, Controlled, Single Blind, Clinical Trial.","status":"TERMINATED","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","isPivotal":false,"enrollment":31,"indication":"Graves Ophthalmopathy","completionDate":"2013-06"},{"nctId":"NCT01458600","phase":"Phase 4","title":"Adjuvant Treatment of Graves´ Ophthalmopathy With NSAID (aGO Study)","status":"COMPLETED","sponsor":"Mikael Lantz","isPivotal":false,"enrollment":65,"indication":"Graves´ Disease","completionDate":"2016-02"},{"nctId":"NCT05607407","phase":"Phase 2","title":"Targeting Transsulfuration Via Suppression of Thyroid Hormone Signaling in Progressive Glioblastoma: Phase 2 and Pharmacodynamic Trial of Methimazole in Patients With Progressive Glioblastoma","status":"RECRUITING","sponsor":"Case Comprehensive Cancer Center","isPivotal":false,"enrollment":19,"indication":"Glioblastoma, Glioma","completionDate":"2026-07"},{"nctId":"NCT06540469","phase":"NA","title":"Effects of Optimal Iodine Supplementation in Anti-thyroid Drug Therapy for Graves' Hyperthyroidism: a Prospective Randomized Controlled Trial","status":"NOT_YET_RECRUITING","sponsor":"Shandong Provincial Hospital","isPivotal":false,"enrollment":315,"indication":"Graves Disease, Hyperthyroidism","completionDate":"2028-07-31"},{"nctId":"NCT02727738","phase":"NA","title":"Randomized Open Clinical Study to Evaluate the Efficacy of Selenium Plus Methimazole for Treatment of Graves' Hyperthyroidism","status":"COMPLETED","sponsor":"University of Pisa","isPivotal":false,"enrollment":30,"indication":"Graves' Disease","completionDate":"2015-12"},{"nctId":"NCT00150124","phase":"Phase 4","title":"The Influence of Continuous Block-replacement Therapy on the Effect of Radioiodine in Patients With Hyperthyroidism","status":"COMPLETED","sponsor":"Steen Bonnema","isPivotal":false,"enrollment":100,"indication":"Toxic Nodular Goitre, Graves' Disease","completionDate":"2009-03"},{"nctId":"NCT07369063","phase":"Phase 2","title":"Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease: A Pilot Feasibility Trial","status":"RECRUITING","sponsor":"Northwell Health","isPivotal":false,"enrollment":30,"indication":"Graves Disease, Graves' Disease","completionDate":"2027-02-28"},{"nctId":"NCT05964452","phase":"N/A","title":"The Efficacy of Cook County Health's Methimazole Dosing Algorithm in the Setting of Ne Onset Graves' Hyperthyroidism","status":"TERMINATED","sponsor":"Cook County Health","isPivotal":false,"enrollment":11,"indication":"Graves Disease","completionDate":"2024-09-17"},{"nctId":"NCT00677469","phase":"NA","title":"Low Doses of Cholestyramine in the Treatment of Hyperthyroidism","status":"COMPLETED","sponsor":"Shiraz University of Medical Sciences","isPivotal":false,"enrollment":45,"indication":"Graves Disease","completionDate":"2008-01"},{"nctId":"NCT04304794","phase":"N/A","title":"Prevention of Iodinated Contrast Media Induced Hyperthyroidism in Patients With Euthyroid Goiter","status":"COMPLETED","sponsor":"Medical University of Warsaw","isPivotal":false,"enrollment":36,"indication":"Hyperthyroidism/Thyrotoxicosis, Hyperthyroidism; Goiter","completionDate":"2020-02-20"},{"nctId":"NCT02812888","phase":"N/A","title":"Serum Betatrophin Levels and Its Influencing Factors in Patients With Hyperthyroidism","status":"UNKNOWN","sponsor":"Hu Hao","isPivotal":false,"enrollment":240,"indication":"Hyperthyroidism","completionDate":"2017-06"},{"nctId":"NCT01849861","phase":"Phase 4","title":"Cardiopulmonary Capacity In Different Quartiles Ranges Of Reference For Serum Thyroid Stimulating Hormone (TSH): Sectional Evaluation And Effect Of The Use Of Methimazole In Elderly Population","status":"UNKNOWN","sponsor":"Universidade Federal do Rio de Janeiro","isPivotal":false,"enrollment":200,"indication":"Healthy","completionDate":"2014-09"},{"nctId":"NCT06068179","phase":"Phase 2","title":"The Efficacy and Safety of Combining Mycophenolate Mofetil With Methimazole on Remission of Newly Diagnosis Graves' Disease (3M-RGD Trial): an Open-label, Randomized Trial","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","isPivotal":true,"enrollment":205,"indication":"Graves' Disease","completionDate":"2026-10-08"},{"nctId":"NCT06327828","phase":"NA","title":"Guiding Methimazole Therapy in Graves' Disease - a Randomised Controlled Trial Comparing a Computer-aided Treatment (Digital Thyroid, DigiThy) Versus Usual Care","status":"NOT_YET_RECRUITING","sponsor":"Medical University of Graz","isPivotal":false,"enrollment":52,"indication":"Graves Disease","completionDate":"2026-10-01"},{"nctId":"NCT04346901","phase":"Phase 1","title":"Comparative Study of mMASI Before and After Hyperthyroid Therapy in Hyperthyroid Subjects With Melasma","status":"COMPLETED","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","isPivotal":false,"enrollment":23,"indication":"Melasma, Hyperthyroidism","completionDate":"2020-02-15"},{"nctId":"NCT00150137","phase":"Phase 4","title":"The Influence of Continuous Treatment With Antithyroid Drugs on the Effect of Radioiodine in Patients With Hyperthyroidism","status":"COMPLETED","sponsor":"Odense University Hospital","isPivotal":false,"enrollment":80,"indication":"Toxic Nodular Goitre, Graves Disease","completionDate":"2004-12"},{"nctId":"NCT01247077","phase":"Phase 2","title":"Neuropsychologic and Immunological Evaluation in Treatment of Thyroid Diseases. Is Selenium Efficient?","status":"COMPLETED","sponsor":"Karolinska Institutet","isPivotal":false,"enrollment":44,"indication":"QoL Before and After 9 Month of Medical Treatment of Graves´Thyrotoxicosis, Potential Effect of Selenium","completionDate":"2014-04"},{"nctId":"NCT06864351","phase":"NA","title":"Prospective Evaluation of OptiThyDose, a Mathematical Model for Calculating Appropriate Dose Ranges in Children With Thyroid Diseases","status":"RECRUITING","sponsor":"University Children's Hospital Basel","isPivotal":false,"enrollment":150,"indication":"Thyroid Diseases, Congenital Hypothyroidism","completionDate":"2029-02"},{"nctId":"NCT06240455","phase":"Phase 2","title":"A Double-blind, Placebo-controlled, Phase 2 Dose-range Study to Assess the Efficacy and Safety of WP1302 in Preventing Disease Relapse Following Methimazole Withdrawal in Subjects With Graves' Disease","status":"SUSPENDED","sponsor":"Worg Biotherapeutics Inc.","isPivotal":false,"enrollment":176,"indication":"Graves Disease","completionDate":"2030-09-30"},{"nctId":"NCT00150111","phase":"Phase 1","title":"B Cell Depletion With the Anti-CD20 Monoclonal Antibody Rituximab in the Treatment of Graves' Disease","status":"COMPLETED","sponsor":"Odense University Hospital","isPivotal":false,"enrollment":20,"indication":"Graves´ Disease, Thyroid Associated Ophthalmopathy","completionDate":"2006-10"},{"nctId":"NCT07040306","phase":"N/A","title":"A Prospective Clinical Follow-up Study of Drug Treatment in Patients With Graves' Disease","status":"RECRUITING","sponsor":"First Hospital of China Medical University","isPivotal":false,"enrollment":1000,"indication":"Graves´ Disease","completionDate":"2030-12-01"},{"nctId":"NCT02654041","phase":"Phase 2","title":"Phase II, Open-label, Prospective, Single-arm, Single-center Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients","status":"TERMINATED","sponsor":"Musli Thyropeutics Ltd.","isPivotal":false,"enrollment":3,"indication":"Glioblastoma Multiforme (GBM)","completionDate":"2017-06"},{"nctId":"NCT03447093","phase":"N/A","title":"The Oral Microbiota in Autoimmune Thyroiditis is Distinctive And Predictive","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","isPivotal":false,"enrollment":120,"indication":"Microbiota","completionDate":"2021-12"},{"nctId":"NCT03433352","phase":"N/A","title":"The Effect of Intestinal Microbiota on Treatment Sensitivity and Prognosis of Methimazole for GD","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","isPivotal":false,"enrollment":90,"indication":"Microbiota","completionDate":"2019-12-20"},{"nctId":"NCT00001421","phase":"Phase 2","title":"A Pilot Study of the Role of Methimazole in Patients With Polymyositis and Dermatomyositis","status":"COMPLETED","sponsor":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)","isPivotal":false,"enrollment":20,"indication":"Dermatomyositis, Polymyositis","completionDate":"2001-04"},{"nctId":"NCT03390582","phase":"N/A","title":"Gut Microbiota is Associated With Autoimmune Thyroid Disease(GD and HT)","status":"UNKNOWN","sponsor":"First Affiliated Hospital of Harbin Medical University","isPivotal":false,"enrollment":200,"indication":"Gut Microbiota","completionDate":"2021-11-01"},{"nctId":"NCT02376088","phase":"N/A","title":"Characteristics of Islet β-cell Functions in Chinese Patients With Graves' Disease","status":"COMPLETED","sponsor":"Weikai Hou","isPivotal":false,"enrollment":328,"indication":"Graves Disease","completionDate":"2014-06"},{"nctId":"NCT04776993","phase":"Phase 3","title":"A Phase III, Randomized, Controlled, Open Label, no Profit, Single-center Intervention Study to Compare the Effect of a Conservative (Antithyroid Drugs) and an Ablative Approach (Radioiodine or Total ","status":"UNKNOWN","sponsor":"University of Pisa","isPivotal":true,"enrollment":52,"indication":"Graves' Orbitopathy","completionDate":"2026-03-01"},{"nctId":"NCT03064542","phase":"N/A","title":"The Role of Thyroid Status in Regulating Brown Adipose Tissue Activity, White Adipose Tissue Partitioning and Resting Energy Expenditure","status":"COMPLETED","sponsor":"Singapore Institute of Food and Biotechnology Innovation","isPivotal":false,"enrollment":30,"indication":"Hyperthyroidism","completionDate":"2023-05-19"},{"nctId":"NCT01560299","phase":"NA","title":"","status":"COMPLETED","sponsor":"Mashhad University of Medical Sciences","isPivotal":false,"enrollment":150,"indication":"Graves Disease","completionDate":"2012-01"},{"nctId":"NCT03066076","phase":"Phase 3","title":"Prospective Randomized Clinical Trial of Total Thyroidectomy (Tx) Versus Thionamides (Anti-Thyroid Drugs) in Patients With Moderate-to-Severe Graves' Ophthalmopathy - a 1-year Follow-up","status":"UNKNOWN","sponsor":"Medical University of Vienna","isPivotal":true,"enrollment":60,"indication":"Graves Disease, Graves Ophthalmopathy","completionDate":"2019-06-01"},{"nctId":"NCT00917241","phase":"Phase 4","title":"Prevention Relapse of Graves' Disease by Treatment With Intrathyroid Injection of Dexamethasone","status":"COMPLETED","sponsor":"Xiao-Ming Mao","isPivotal":false,"enrollment":218,"indication":"Graves' Disease","completionDate":"2009-03"},{"nctId":"NCT04946123","phase":"NA","title":"Association of Methimazole With L-carnitine and Selenium in Patients With Hyperthyroidism","status":"COMPLETED","sponsor":"Lo.Li.Pharma s.r.l","isPivotal":false,"enrollment":60,"indication":"Hyperthyroidism","completionDate":"2025-06-04"},{"nctId":"NCT05461820","phase":"Phase 4","title":"Clinical Study on the Effect of Routine Treatment and Intensive Treatment on the Regulation of Graves' Disease and the Cumulative Recurrence Two Years After Drug Withdrawal","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","isPivotal":false,"enrollment":240,"indication":"Graves Disease, Relapse","completionDate":"2030-07-31"}],"genericFilers":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}